Stamford Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Stamford Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma (NCT06344052) | Stamford Pharmaceuticals, Inc. | 2024-04-09 |
Track Stamford Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.